Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

A woman's liver problems improved after she stopped taking spironolactone.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

SOX11 and SOX4 help skin cells act like embryonic cells to heal wounds in mice.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.